CareRx Corp's recent earnings report shows a significant miss in EPS estimates, raising questions about the company's growth in the healthcare sector.
On July 29, 2026, CareRx Corp (CRRX.TO) announced its earnings for the fiscal period ending June 30, 2026, reporting an earnings per share (EPS) of $0.01. This was well below the consensus estimate of $0.03, resulting in a surprise of -66.67%. The company’s performance has been inconsistent, reflecting the challenges it faces in a competitive healthcare market.
Recent earnings trend
Advertisement
Earn cash back with a smarter spending account
Open a KOHO account and start earning on everyday purchases — no annual fee on the base plan.
CareRx Corp
CRRX.TO
CRRX.TO
CareRx Corp
WealthAwesomeMarket cap
$230.31M
P/E
8.6x
Div. yield
2.25%
Div. / share
$0.08
52W high
$3.95
52W low
$2.71
1W change
+7.40%
Beta
0.60
Analyst Price Targets
Based on analyst covering CRRX
Wall Street analysts forecast CRRX stock price to rise 41.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$5.14
+41.7% Upside
Current Price
C$3.63
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CRRX's historical volatility
30-Day Vol
22.6%
Annualized
90-Day Vol
26.0%
Annualized
Trend (90d)
-3.5%
Annualized drift
90d Mean
C$3.59
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$3.62 | C$3.34 – C$3.91 |
| 60 trading days | C$3.60 | C$3.23 – C$4.02 |
| 90 trading days | C$3.59 | C$3.13 – C$4.10 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-06-30 | 2026-07-29 | 0.0100 | 0.0300 | -66.7% |
| 2026-03-31 | 2026-05-06 | 0.0200 | 0.0700 | -71.4% |
| 2025-12-31 | 2026-03-04 | 0.3700 | 0.0300 | +1133.3% |
| 2025-09-30 | 2025-11-03 | 0.0200 | 0.0300 | -33.3% |
| 2025-06-30 | 2025-07-30 | 0.0100 | 0.0100 | +0.0% |
| 2025-03-31 | 2025-05-07 | 0.0035 | 0.0100 | -65.0% |
Advertisement
Investor takeaway: Investors should note CareRx's disappointing earnings miss, which may indicate deeper operational issues or market challenges. The low EPS against expectations could impact investor sentiment and stock performance in the near future.
EPS Misses by 66.67%, Revenue Growth Estimates at 5%
CareRx's actual EPS of $0.01 starkly contrasts with the estimate of $0.03, highlighting ongoing difficulties in meeting financial targets. The revenue consensus stands at $95.98 million, with a growth estimate of 5% for the upcoming periods.
Bull case
Despite the earnings miss, CareRx offers a solid dividend yield of 2.25% and a relatively low P/E ratio of 8.64, suggesting potential value for long-term investors. The company has also maintained a market cap of about CAD 230 million, indicating some level of investor confidence.
Bear case
The significant earnings miss, along with a history of inconsistent EPS results, raises concerns about CareRx's ability to meet future growth targets. With a surprise of -66.67% and only one earnings beat in the last four quarters, the company may find it challenging to regain investor trust.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
